Multiple Sclerosis Jessica Kelly-Hannon 11322301 It’s causes, effects and treatments.

Slides:



Advertisements
Similar presentations
MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Advertisements

A&P Signs & Symptoms Management of condition
An Introduction to Multiple Sclerosis. What is MS? Common symptoms. Diagnosis & potential treatments. Case Studies Support for people with MS and carers.
Multiple Sclerosis Kristen Meyer. Indroduction Definition Epidemiology Symptoms Diagnosis Tests and Evaluations Complications Treatment Effects on Exercise.
Overview of Multiple Sclerosis  Valerie Robinson, D.O. 
Multiple Sclerosis Definition: Multiple sclerosis (MS) is a disease of the central nervous system (CNS); it damages the protective coating around the.
What is MS? Multiple Sclerosis (MS) is an inflammatory disease of the Central Nervous System (CNS) - that's the brain and spinal cord. Predominantly,
Rituximab (RITUXAN) & Multiple Sclerosis
Original Article B-Cell Depletion with Rituximab in Relapsing- Remitting Multiple Sclerosis Stephen L. Hauser, M.D., Emmanuelle Waubant, M.D., Ph.D., Douglas.
Multiple Sclerosis & Treatment of Progression with Interferon-Beta-1a
Multiple Sclerosis Melissa, Shelcie, Natalie. Description Multiple sclerosis (MS) is an unpredictable, often disabling disease of the central nervous.
MULTIPLE SCLEROSIS CLAIRE BISCHOFF, ASHLEY FOLDEN, AND CASSIE NEWMAN.
Multiple Sclerosis Presentation: Dallia Facts: Madison Visuals: Anastasia Veloudos.
By Amanda Rossi. Multiple Sclerosis, also known as ‘MS,’ is a long- term disease that effects the brain and spinal cord. This impacts the functions of.
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 23 Drugs for Multiple Sclerosis.
By Matthew Sampson. Overview What is it? Previous Treatments Monoclonal Antibodies Chimeric Molecules Oral Therapies Hematopoietic Stem Cells Future.
Multiple Sclerosis (MS) By: Morgan Farr Biology 1010.
Multiple Sclerosis (Definition)  “Multiple Sclerosis is a progressive demyelination of neurons in the central nervous system (the Brain and the Spinal.
Multiple Sclerosis BY: SARAH BURGESS. “For every male that is diagnosed with multiple sclerosis there is three women diagnosed”
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Friends With MS.com Bringing you support and information for Multiple Sclerosis.
Pediatric Neurology Use of Biologic and Chemotherapeutic Agents Pediatric Neurology Use of Biologic and Chemotherapeutic Agents.
Adam Percey. What is it?  MS is a disease of the central nervous system.  What happens is the myelin sheaths around the axon of a nerve fade away. These.
Multiple Sclerosis Rohith M. Reddy. Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system.
Multiple Sclerosis (MS) Henry Wilson March 6, 2013 Honors Psychology 4th.
Multiple Sclerosis Brett Catlin Period Seven September 3 rd, 2003.
Multiple Sclerosis Alan Chen 4/1/14. General Information Other names: disseminated sclerosis or encephalomyelitis disseminata Inflammatory disease that.
Disease modifying drugs in MS Eva Havrdová Charles University, First Medical Faculty, Dpt. of Neurology Praha, Czech Republic.
© 2014 Direct One Communications, Inc. All rights reserved. 1 A New Era of Therapy in Multiple Sclerosis: Balancing the Options and Challenges Ahead Jennifer.
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
Multiple Sclerosis. Incidence 85,000 patient in UK Cases present between 20-40yrs of age Twice as many females Not a fatal condition, most patients have.
Multiple Sclerosis Jesse Mohoric and Sarah Davis.
Adult Medical-Surgical Nursing Neurology Module: Multiple Sclerosis.
Cerebral Palsy Muscular Dystrophy Multiple Sclerosis Catapulting, Mischievous, Killer.
GROUP MEMBERS  Vanessa Wickham  Satrupa Devi Singh  Joshua Griffith  Jennifer Hayner  Carlwyn Collins  Ashley Singh.
Human Physiology Multiple Scolerosis. Multiple sclerosis is an autoimmune disease that affects the brain and spinal cord (central nervous system) autoimmune.
MULTIPLE SCLEROSIS Ana Costas Barreiro.
MS مولتیپل اسکلروزیس. Client with Multiple Sclerosis Description Chronic demyelinating disease of CNS associated with - abnormal immune response to environmental.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
CASE 1 Olivia Clements, Cade Mersch, and Julia Calhoun.
Neurological Disorders
Sacha Ingram & Masai Kofa.  Multiple Sclerosis is an autoimmune disease affecting the central nervous system, causing permanent damage to the myelin.
Multiple Sclerosis By: Sandra Bachaalany MIM Virtual Camp Project.
What is Multiple Sclerosis (MS)? Autoimmune disease Affects 2.3 million people in the world 3 Types Relapsing-remmitting Primary-progressive Secondary-progressive.
Christiane’s part. In Multiple Sclerosis (or "MS") a loss of the nerves' axon coating myelin prohibits the nerve axons from efficiently conducting action.
Multiple Sclerosis By Birger Flønæs & Christoffer Brovold.
MULTIPLE SCLEROSIS BY EMILY HOWARD. Multiple Sclerosis (MS) Multiple sclerosis (or MS) is a chronic, often disabling disease of the immune system that.
Multiple Sclerosis And Controversies Around it University of Puerto Rico in Humacao.
Zookeeper genetic disorder By nick proffitt. Multiple sclerosis Multiple sclerosis also known as MS is a long lasting disease that can affect the brain.
Multiple Sclerosis By Kelsey Dussault May 23, 2011.
Do Now 2/9/15 1.Describe possible causes for forgetting a memory. 2.Compare and contrast semantic and episodic memories.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Natalizumab: Bench to Bedside and Beyond JAMA Neurol.
Multiple Sclerosis (MS) a serious, chronic and debilitating disease What is MS? A disease of the brain and spinal cord.
Nursing management of Multiple sclerosis
Multiple Sclerosis Ian Haslam 486. What is Multiple Sclerosis? An autoimmune disease that attacks the bodies own nerve cells Leads to partial disability.
Multiple Sclerosis. What is Multiple Sclerosis?  It is an Auto Immune Disease which is when the body starts to destroy itself.  It is a life-long disease.
Four Known Types of MS Clinically isolated syndrome (CIS)
Do Now.
Natalizumab (Approved, Investigational)
Claire Bischoff, Ashley folden, and Cassie Newman
Autoimmunity: Introduction
By: Julie Carrasco, Brianna Macias, Alexx Rusake
Dysfunctions of the musculo-skeletal system
Belle Huffman Biology 430 Dr. Spilatro
Stephen L. Hauser, Jorge R. Oksenberg  Neuron 
Multiple Sclerosis Awareness
Treatment of Multiple Sclerosis: Old & New
Multiple Sclerosis is a neurological, immune-mediated disorder
Disease of the Central Nervous System By Eric Nauman
Presentation transcript:

Multiple Sclerosis Jessica Kelly-Hannon It’s causes, effects and treatments

What is Multiple Sclerosis? Multiple Sclerosis is an inflammatory autoimmune disorder of the brain and spinal chord. It causes severe demyelination of axons. This demyelination causes chronic neurodegeneration and leads to loss of movement and eventually severe disability. There is no cure for Multiple Sclerosis, only treatments to extend and improve life quality.

What is Multiple Sclerosis? Multiple Sclerosis can be difficult to diagnose as initial symptoms usually resolve themselves over a short period of time. This is a hallmark of MS, as symptoms will appear and disappear, lasting for short periods of time and then disappearing entirely. This is known as relapsing, remitting, multiple sclerosis (RRMS). As the disease progresses the time spent in remission decreases, and the patient’s disability increasing. Contrasting to this a patient could have slow and progressive onset of MS where symptoms continue to get worse over time. This is called Primary Progressive Multiple Sclerosis.

What causes Multiple Sclerosis? We don’t know the primary cause of MS but we do have an idea about some possible causes: Environmental factors: Migration, Diet, Poison, Infection, and Viruses have all been considered as causation factors of MS Genetic Factors:MS is not thought to be an inherited disease but it has been noted that MS occurrence is somewhat increased in someone who has a close relative with the disease.

How do we Diagnose Multiple Sclerosis? MS can be difficult to diagnose initially as symptoms of the disease can easily be attributed to other problems and as all symptoms generally subside after a short time, these symptoms don’t cause a lot of alarm. Common symptoms include: Tingling, pins and needles or numbness Muscle weakness (generally in one or both legs) Chronic pain Muscle spasm

Combining these early symptoms with: supporting medical imagery, such as MRI And laboratory testing, such as testing the cerebrospinal fluid (CSF) acquired through a lumbar puncture, Enable us to more accurately diagnose MS. How do we Diagnose Multiple Sclerosis?

Types Of Multiple Sclerosis There are 4 types of MS: Relapsing-Remitting Secondary Progressive Primary Progressive Progressive Relapsing There is also benign MS where the initial symptoms are present but full remission occurs and partial or permeant disability does not occur

Available Treatments. Current treatments for MS include: Drug treatment: High-dose methyl prednisolone β-interferons such as Rebif, Avonex, and Betaferon Copaxone (glatiramer acetate) Natilizumab (humanised monoclonal antibody) Regular exercise Lifestyle changes

Natalizumab Treatment Natalizumab is a humanised monoclonal antibody, administered intravenously. It’s action is against the cell adhesion molecule α4-integrin receptor molecules. It’s action is believed to reduce the ability of imflammatory immune cells to attach and cross the blood-brain barrier (BBB). In MS this effect is believed to occur on cells expressing VCAM-1 and in parenchymal cells expressing the osteopontin gene. Repeated treatment reduces the amount of leukocytes migrating into the brain.

Future Treatments Although a cure for MS seems far in the future, there are new drugs that show some promise. One such drug is Alemtazumab which is a humanised monoclonal antibody originally made for leukemia but showing promise is the treatment of MS.

Alemtuzumab Treatment Originally made in Cambridge it was called Campath. Is a humanised monoclonal antibody. It’s action sees it bind to CD52, a protein on the surface of mature lymphocytes causing them to be them to be targeted for destruction. The drug is in trial phases for MS at the moment but it is thought that is will be combined with Copaxone as it is expected to work synergistically. During trials it has shown promise when compared against interferon beta 1α.

Conclusion MS is a progressive debilitating disease. It’s onset symptoms lead to poor diagnosis although this is improving. Treatments focus on reducing relapses and improving quality of life of patients. No cure has yet been found. Future drug treatments and drug combinations are showing promising results